Survival trends among non‐small‐cell lung cancer patients over a decade: impact of initial therapy at academic centers
Yanyan Lou(Jacksonville College), Sikander Ailawadhi(Jacksonville College)
Cited by 34
Related Papers
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma
|New England Journal of Medicine|2023|695
Next generation of immune checkpoint inhibitors and beyond
|Journal of Hematology & Oncology|2021|537
Targeted therapy in advanced non-small cell lung cancer: current advances and future trends
|Journal of Hematology & Oncology|2021|271
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
|Journal for ImmunoTherapy of Cancer|2022|140